Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 06, 2024

BUY
$223.05 - $302.68 $309,147 - $419,514
1,386 New
1,386 $395,000
Q2 2023

Nov 21, 2023

BUY
$223.05 - $302.68 $309,147 - $419,514
1,386 New
1,386 $395,000
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $309,147 - $419,514
1,386 New
1,386 $395,000
Q4 2020

Feb 12, 2021

SELL
$67.44 - $103.72 $71.9 Million - $111 Million
-1,066,016 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$42.79 - $75.8 $2.57 Million - $4.55 Million
60,000 Added 5.96%
1,066,016 $80.8 Million
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $8.68 Million - $15.1 Million
-318,528 Reduced 24.05%
1,006,016 $47.7 Million
Q1 2020

Apr 09, 2020

BUY
$23.16 - $47.74 $13.9 Million - $28.6 Million
599,687 Added 82.73%
1,324,544 $43.9 Million
Q4 2019

Jan 16, 2020

BUY
$29.4 - $44.98 $21.3 Million - $32.6 Million
724,857 New
724,857 $31.8 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.